We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

MorphoSys and Emergent BioSolutions Initiate Phase 1 Clinical Study

News   Mar 11, 2015

 
MorphoSys and Emergent BioSolutions Initiate Phase 1 Clinical Study
 
 
Advertisement
 

RELATED ARTICLES

Algorithms Uncover Cancers’ Unseen Genetic Losses and Gains

News

Scientists have created new mathematical tools that allow scientists to search the vast collection of DNA snippets and uncover whether there are either missing pieces or duplicates. These algorithms, dubbed HATCHet and CHISEL, could help to improve diagnosis and treatment.

READ MORE

Phase 3 Clinical Trial of Belimumab for Lupus Nephritis Reports Positive Results

News

Results from the largest Phase 3 lupus nephritis clinical trial ever conducted were announced, September 16. The study, found positive results of the efficacy and safety of the drug belimumab in patients with active lupus nephritis, a condition that causes inflammation in the kidneys of patients with systemic lupus erythematosus.

READ MORE

Investigating How the Immune System Detects “Hidden” Threats

News

A new study has led to a better understanding of how key components of the body’s immune system find intruding or damaged cells, which could lead to novel therapeutic approaches against viral infection and cancer.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE